Search

Pelodiscus sinensis meat is a nutritional food and tonic with angiotensin-converting enzyme (ACE) inhibitory activities. To identify the bioactive substances responsible, several bioinformatics methods were integrated to enable a virtual screening for bioactive peptides in proteins identified within a water-soluble protein fraction of Pelodiscus sinensis meat by Shotgun proteomics. The peptides were generated from the identified proteins by in silico proteolysis using six proteases. A comparison of the numbers of proteins suitable for digestion with each enzyme and the iBAQ (intensity-based absolute quantification) values for these proteins revealed that bromelain and papain were the most suitable proteases for this sample. Next, the water solubility, toxicity, and ADMET (absorption/distribution/metabolism/excretion/toxicity) properties of these peptides were evaluated in silico. Finally, a novel ACE inhibitory peptide IEWEF with an IC50 value of 41.33 µM was identified. The activity of the synthesized peptide was verified in vitro, and it was shown to be a non-competitive ACE inhibitor. Molecular docking revealed that IEWEF could tightly bind to C-ACE, and N-ACE with energies less than 0 kJ mol−1, and the peptide IEWEF can form hydrogen bonds with C-ACE and N-ACE respectively. These results provide evidence that bioactive peptides in the water-soluble protein fraction account for (at least) some of the ACE inhibitory activities observed in Pelodiscus sinensis meat. Furthermore, our research provides a workflow for the efficient identification of novel ACE inhibitory peptides from complex protein mixtures. [ABSTRACT FROM AUTHOR]

The safety of the military and civilian industries is threatened by the combustion–explosion of energetic materials during production, transport, and storage. Black powder, a commonly used energetic material, has been widely utilized in special ammunition, detonating cord, explosive welding, and fireworks, and it has caused several accidents. To address this issue, a new type of seawater microcapsule suppressant has been developed using natural seawater, which is both clean and environmentally friendly. This study examines the effectiveness of different dosages and types of suppressants in reducing the combustion–explosion pressure of black powder, an energetic material. The dosage of suppressants required for complete suppression is estimated, and changes in flame and wall temperature are monitored to analyze the combustion–explosion suppression efficiency and mechanism of black powder. The experimental results demonstrate that the newly developed seawater microcapsule has a positive impact on suppressing the combustion–explosion in black powder. When using 0.15 g of seawater microcapsules, there was a 32.51% reduction in the maximum explosion pressure of 1 g of black powder and a 60.32% decrease in the maximum explosion rise rate. [ABSTRACT FROM AUTHOR]

Neoadjuvant chemoimmunotherapy has emerged as a potential treatment option for resectable head and neck squamous cell carcinoma (HNSCC). In this single-arm phase II trial (NCT04826679), patients with resectable locally advanced HNSCC (T2‒T4, N0‒N3b, M0) received neoadjuvant chemoimmunotherapy with camrelizumab (200 mg), nab-paclitaxel (260 mg/m2), and cisplatin (60 mg/m2) intravenously on day one of each three-week cycle for three cycles. The primary endpoint was the objective response rate (ORR). Secondary endpoints included pathologic complete response (pCR), major pathologic response (MPR), two-year progression-free survival rate, two-year overall survival rate, and toxicities. Here, we report the perioperative outcomes; survival outcomes were not mature at the time of data analysis. Between April 19, 2021 and March 17, 2022, 48 patients were enrolled and received neoadjuvant therapy, 27 of whom proceeded to surgical resection and remaining 21 received non-surgical therapy. The ORR was 89.6% (95% CI: 80.9, 98.2) among 48 patients who completed neoadjuvant therapy. Of the 27 patients who underwent surgery, 17 (63.0%, 95% CI: 44.7, 81.2) achieved a MPR or pCR, with a pCR rate of 55.6% (95% CI: 36.8, 74.3). Treatment-related adverse events of grade 3 or 4 occurred in two patients. This study meets the primary endpoint showing potential efficacy of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin, with an acceptable safety profile, in patients with resectable locally advanced HNSCC.Neoadjuvant chemo-immunotherapy represents a therapeutic option for resectable head and neck squamous cell carcinoma (HNSCC). Here the authors report the results of a phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced HNSCC. [ABSTRACT FROM AUTHOR]

Recyclability of thermosetting polymers and their composites is a challenge for alleviating environmental pollution and resource waste. In this study, solvent-recyclable thermosetting polyimide (PI) and its composite were successfully synthesized. The tensile strength, elongation at break, and Young's modulus of PI are 108.70 ± 7.29 MPa, 19.35% ± 3.89%, and 2336.42 ± 128.00 MPa, respectively. The addition of reduced graphene oxide (RGO) not only enhances the mechanical properties of PI but also endows it with excellent tribological properties. The PI illustrates a high recycling efficiency of 94.15%, but the recycled composite exhibits inferior mechanical properties. The recycling and utilization of PI and its composite are realized through imine bonds (–C=N), which provides new guidance for solving the problem of environmental pollution and resource waste and is potential application in the field of sustainable tribology. [ABSTRACT FROM AUTHOR]